That CELA3B immunostaining was only weak in a fraction of our acinar cell carcinomas is consistent with earlier data describing a reduced CELA3B expression in pancreatic cancer cell lines and tissues as compared to adjacent pancreatic normal tissues [26]. This evidence concerns the gene CELA3B and acinar cell carcinoma.